Capital Investment Advisory Services, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Capital Investment Advisory Services, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 25, 2021	SELL	$478.3 - $607.98 $173,622 - $220,696	-363 Closed	0 $0
Q3 2020 Oct 19, 2020	BUY	$544.75 - $658.21 $1,089 - $1,316	2 Added 0.55%	363 $203,000
Q2 2020 Aug 05, 2020	SELL	$493.32 - $643.92 $49,332 - $64,391	-100 Reduced 21.69%	361 $225,000
Q1 2020 Apr 28, 2020	BUY	$336.18 - $494.43 $154,978 - $227,932	461 New	461 $225,000
Q4 2019 Feb 04, 2020	SELL	$274.13 - $376.51 $57,841 - $79,443	-211 Closed	0 $0
Q2 2019 Aug 08, 2019	BUY	$299.6 - $414.82 $59,920 - $82,964	200 Added 1818.18%	211 $63,000
Q4 2018 Feb 04, 2019	BUY	$335.82 - $403.04 $3,694 - $4,433	11 New	11 $4,000

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Capital Investment Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Investment Advisory Services, LLC with notifications on news.